Hematopoietic targets of radiation: identification and mitigation
Hematopoietic targets of radiation: identification and mitigation
批准号:
8071786
负责人:
James Palis
金额:
$0.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-22 至 2010-09-30
关键词:
AcuteAnemiaBiologicalBiological ModelsBlood CellsBlood PlateletsBlood VesselsBone MarrowBreathingCell DeathCellsChronicCommitComplexDisastersDoseEmployee StrikesErythroblastsErythrocytesErythroidErythropoietinExposure toExternal Beam Radiation TherapyFaceFibroblast Growth Factor 2FutureGamma RaysGrowth FactorHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHemorrhageInfectionIngestionIslandKineticsLeadLearningLeukocytesLifeMarrowMegakaryocytesModelingMolecularMusNuclearNuclear AccidentsParticulateProcessPublic HealthRadiationRadiation InjuriesRadiation ToleranceRadioactiveRecoveryResearchSiteSyndromeSystemTestingThrombopoietinUniversitiesabstractingcytokinecytokine therapycytopeniadesignimprovedinternal radiationirradiationnovelnovel strategiesperipheral bloodprecursor cellprogenitorradiation effectresponse
中文摘要
摘要
造血系统对辐射损伤非常敏感,然而,
造血祖细胞和前体中间体的特异性放射敏感性
骨髓的复杂环境。这一建议的重点是理解,从而更好地
减轻辐射对红细胞和巨核细胞谱系的影响,
来自共同的双能祖细胞,共享几种细胞因子生长因子,但具有不同的
细胞生态位和独特的前体成熟过程。我们假设他们的
生物学差异导致不同的辐射敏感性,它们的共同特征提供了
共同缓解的机会。在目标1中,我们将确定不同的放射敏感性
红细胞和巨核细胞的祖细胞和前体细胞。已知几种细胞因子
保护红细胞和巨核细胞前体细胞免于细胞死亡。在目标2中,我们定义
单一和联合细胞因子治疗减轻放射损伤能力及探索
是否这两个谱系从一个共同的祖先出现导致细胞因子
治疗有利于减轻一个血统的损害其他。在目标3中,我们
研究辐射对红细胞和巨核细胞前体的不同小生境的损伤,
从而为未来缓解造血前体的新方法奠定基础
通过保护他们的细胞龛。生物恐怖袭击或重大核灾难不会导致
急性外照射,但也可能涉及二次内照射
通过吸入和摄入放射性微粒,正如在一些
核事故。在目标4中,我们将利用内暴露的小鼠模型
最近在罗切斯特大学建立,开始描绘慢性,
低剂量的骨髓内照射更好地了解
造血系统及其微环境对辐射暴露的影响将提供合理的
在发生核事故或核攻击时采取缓解核威胁的方法,从而加强
造血恢复和提高原发性受害者及其救助者存活率。公共卫生声明:拟议的研究旨在了解
骨髓中的血细胞对辐射很敏感,
这些细胞。
英文摘要
Abstract
The hematopoietic system is exquisitely sensitive to radiation injury, however, little is known of
the specific radiosensitivity of hematopoietic progenitor and precursors intermediates in the
complex milieu of the marrow. This proposal is focused on understanding, and thus better
mitigating, the effects of radiation on the erythroid and megakaryocyte lineages that originate
from a common bipotential progenitor, share several cytokine growth factors, but have distinct
cellular niches and unique processes of precursor maturation. We hypothesize that their
biological differences lead to differential radiation sensitivity and their shared features provide
opportunities for common mitigation. In Aim 1, we will determine the differential radiosensitivity
of erythroid and megakaryocyte progenitors and precursors. Several cytokines are known to
protect both erythroid and megakaryocyte precursors from cell death. In Aim 2, we will define
the ability of single and combination cytokine therapy to mitigate radiation injury and explore
whether the emergence of these two lineages from a common progenitor causes cytokine
therapy to favor the mitigation of one lineage to the detriment of the other. In Aim 3, we will
investigate radiation damage to the distinct niches of erythroid and megakaryocyte precursors,
and thus lay the groundwork for future novel approaches of mitigating hematopoietic precursors
by protecting their cellular niches. A bioterrorist attack or major nuclear disaster would lead not
only to acute external radiation exposure, but may also involve secondary internal exposure
through inhalation and ingestion of radioactive particulates, as has been seen in a number of
nuclear incidents. In Aim 4, we will take advantage of a murine model of internal exposure
recently established at the University of Rochester to begin to delineate the effects of chronic,
low dose, internal radiation on the bone marrow. A better understanding of the response of the
hematopoietic system and its microenvironment to radiation exposure will provide for a rational
approach to its mitigation in the face of a nuclear accident or attack and, thus, enhance
hematopoietic recovery and improve survival of primary victims as well their rescuers. PUBLIC HEALTH STATEMENT: The proposed research is designed to learn which
blood cells in the bone marrow are sensitive to radiation and to learn how to protect
these cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Embryonic natural killer cell development and function
-
批准号:10661496
-
项目类别:
-
资助金额:$57.94万
-
财政年份:2021
-
负责人:James Palis
-
依托单位:
Embryonic natural killer cell development and function
-
批准号:10328573
-
项目类别:
-
资助金额:$58.83万
-
财政年份:2021
-
负责人:James Palis
-
依托单位:
Megakaryocyte and platelet ontogeny
-
批准号:8829970
-
项目类别:
-
资助金额:$5.17万
-
财政年份:2013
-
负责人:James Palis
-
依托单位:
2013 Red Cells Gordon Research Conference & Gordon Research Seminar
-
批准号:8525933
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2013
-
负责人:James Palis
-
依托单位:
Megakaryocyte and platelet ontogeny
-
批准号:8694029
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2013
-
负责人:James Palis
-
依托单位:
Megakaryocyte and platelet ontogeny
-
批准号:9043868
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2013
-
负责人:James Palis
-
依托单位:
Megakaryocyte and platelet ontogeny
-
批准号:8478982
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2013
-
负责人:James Palis
-
依托单位:
Megakaryocyte and platelet ontogeny
-
批准号:9264520
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2013
-
负责人:James Palis
-
依托单位:
Role of EPO in terminal erythroid maturation
-
批准号:8685321
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2012
-
负责人:James Palis
-
依托单位:
Role of EPO in terminal erythroid maturation
-
批准号:8875051
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2012
-
负责人:James Palis
-
依托单位:
Role of EPO in terminal erythroid maturation
-
批准号:8417125
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2012
-
负责人:James Palis
-
依托单位:
Role of EPO in terminal erythroid maturation
-
批准号:8550826
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2012
-
负责人:James Palis
-
依托单位:
Bone Marrow - Mitigation of Bone Marrow Radiation Injury
-
批准号:8010013
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2010
-
负责人:James Palis
-
依托单位:
Initiation of Mammalian Embryonic Hematopoiesis
-
批准号:8009927
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2010
-
负责人:James Palis
-
依托单位:
Hematopoietic targets of radiation: identification and mitigation
-
批准号:7922949
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2009
-
负责人:James Palis
-
依托单位:
Initiation of Mammalian Embryonic Hematopoiesis
-
批准号:7893948
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2009
-
负责人:James Palis
-
依托单位:
Hematopoietic targets of radiation: identification and mitigation
-
批准号:7661536
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:James Palis
-
依托单位:
Hematopoietic targets of radiation: identification and mitigation
-
批准号:7556565
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:James Palis
-
依托单位:
Hematopoietic targets of radiation: identification and mitigation
-
批准号:7904969
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2008
-
负责人:James Palis
-
依托单位:
Hematopoietic targets of radiation: identification and mitigation
-
批准号:8076304
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2008
-
负责人:James Palis
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: